Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G
Leukemia. 5(10):886-91.
In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte–macrophage colony-stimulating factor.
Carlo-Stella C
Bone Marrow Transplant. 8(4):265-73.
Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
Ottmann OG
Exp Hematol. 19(8):773-8.
Human peripheral blood mononuclear cell subfractionation using counterflow centrifugation elutriation.
Almici C
Haematologica. 76(2):89-93.
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers.
Bergamaschi G
Br J Haematol. 78(2):167-72.
Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C
Leukemia. 4(8):561-6.
Tumor necrosis factor alpha down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G
Leukemia. 4(6):426-30.
In vitro and in vivo effects of recombinant interferon gamma on the growth of hematopoietic progenitor cells from patients with myelodysplastic syndrome.
Rosti V
Haematologica. 74(5):435-40.
Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
Carlo-Stella C
Leukemia. 3(5):363-6.
In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
Carlo-Stella C
Haematologica. 74(2):181-6.